AnnJi Pharmaceutical Company Description

AnnJi Pharmaceutical Co., Ltd. develops drugs in the therapeutic areas of neurology, dermatology, and inflammatory disorders.

It develops therapeutics, such as AJ201 for the treatment of spinal and bulbar muscular atrophy, a neurodegenerative disease; AJ202 for androgenetic alopecia; AJ302, a histone deacetylase 6 inhibitor for the prevention and treatment of chemotherapy-induced peripheral neuropathy; and AJ303, an anti-fibrotic and anti-inflammatory compound for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases.

AnnJi Pharmaceutical Co., Ltd. was founded in 2014 and is based in Taipei, Taiwan.

AnnJi Pharmaceutical Co., Ltd.

Country	Taiwan
Founded	2014
Industry	Biotechnology
Sector	Healthcare
CEO	Wenying Huang

Contact Details

Address: 16F.-6, No. 508, Sec. 7 Taipei, 115011 Taiwan
Phone	886 2 2365 5677
Website	ajpharm.com

Stock Details

Ticker Symbol	7754
Exchange	Taipei Exchange
Fiscal Year	January - December
Reporting Currency	TWD
ISIN Number	TW0007754004
SIC Code	2834

Key Executives

Name	Position
Wenying Huang	Chief Executive Officer
Lewis Yeh	Chief Financial Officer